- Business
- Longevity Health Holdings, Inc. (XAGEW) operates as a bio-aesthetics company focused on developing, manufacturing, and marketing regenerative skincare and haircare products that leverage human-derived bioactive materials to promote skin and hair health. Founded in 2008 and headquartered in Pittsburgh, Pennsylvania, the company offers Carmell Secretome, a blend of growth factors, proteins, peptides, and bio-lipids derived from allogeneic human platelets; Elevai Exosomes, containing growth factors, cytokines, peptides, and other molecules involved in natural healing; and a microemulsion delivery system enabling lipophilic and hydrophilic ingredients without common harmful excipients. It serves dermatologists, plastic surgeons, and consumers primarily in the United States through its carmellcosmetics.com platform and physician networks. In March 2025, the company, formerly Carmell Corporation, rebranded to Longevity Health Holdings, Inc. to emphasize expansion into longevity and healthy aging segments including diagnostics and nutrition, while acquiring Elevai Skincare, Inc. in January 2025 to integrate stem cell exosome technology and boost sales. Recent developments include executing a merger agreement with 20/20 BioLabs in April 2025 to double fiscal 2025 revenue forecasts, raising $1.96 million via at-the-market equity sales in May 2025 to extend cash runway, announcing a $59 million all-stock merger with THPlasma (True Health Inc.) in July 2025 to enter plasma-derived therapeutics with $100 million in sales offtake agreements, and planning Q2 2025 launches of Hair Growth Serum, Soapless Facial Cleanser, Undereye Crème, and VSA Toning Moisturizer.